Diagnostic assays for identification of microorganisms and antimicrobial resistance determinants directly from positive blood culture broth

Clinics in Laboratory Medicine

Volumn 33, Issue 3, 2013, Pages 651-684

  Pence, Morgan A ^a   McElvania TeKippe, Erin ^a   Burnham, Carey Ann D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Blood culture; Molecular diagnostics; MRSA; Rapid pathogen detection; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; CLINDAMYCIN; FLUCONAZOLE; MEROPENEM; METICILLIN; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL RESISTANCE; AUTOMATION; BACTERIOPHAGE; BLOOD CULTURE; BLOODSTREAM INFECTION; CENTRIFUGATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTER PROGRAM; COMPUTER SYSTEM; COST BENEFIT ANALYSIS; COST CONTROL; DEVICE APPROVAL; ELECTROSPRAY MASS SPECTROMETRY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD AND DRUG ADMINISTRATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRAM STAINING; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIAL IDENTIFICATION; MICROSCOPY; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; REVIEW; SENSITIVITY ANALYSIS; THERAPY DELAY; TREATMENT DURATION; VANCOMYCIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS;

BACTEREMIA; BLOOD CULTURE; MOLECULAR DIAGNOSTICS; MRSA; RAPID PATHOGEN DETECTION; STAPHYLOCOCCUS AUREUS;

AUTOMATION; BLOOD; DRUG RESISTANCE, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAM-POSITIVE BACTERIA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL TECHNIQUES; POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAPHYLOCOCCAL INFECTIONS;

EID: 84881517805     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2013.03.010     Document Type: Review

References (154)

1. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008, 34(1):17-60.
2. Weinstein M.P., Murphy J.R., Reller L.B., et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983, 5(1):54-70.
3. Weinstein M.P., Doern G.V. Acritical appraisal of the role of the clinical microbiology laboratory in the diagnosis of bloodstream infections. JClin Microbiol 2011, 49(9S):S26-S29.
4. Beekmann S.E., Diekema D.J., Chapin K.C., et al. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. JClin Microbiol 2003, 41(7):3119-3125.
5. Washington J.A. Blood cultures: principles and techniques. Mayo Clin Proc 1975, 50(2):91-98.
6. Brown D.R., Kutler D., Rai B., et al. Bacterial concentration and blood volume required for a positive blood culture. JPerinatol 1995, 15(2):157-159.
7. Connell T.G., Rele M., Cowley D., et al. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007, 119(5):891-896.
8. Sarkar S., Bhagat I., DeCristofaro J.D., et al. Astudy of the role of multiple site blood cultures in the evaluation of neonatal sepsis. JPerinatol 2006, 26(1):18-22.
9. Schelonka R.L., Chai M.K., Yoder B.A., et al. Volume of blood required to detect common neonatal pathogens. JPediatr 1996, 129(2):275-278.
10. Lin H.H., Liu Y.F., Tien N., et al. Evaluation of the blood volume effect on the diagnosis of bacteremia in automated blood culture systems. JMicrobiol Immunol Infect 2013, 46(1):48-52.
11. Cockerill F.R., Wilson J.W., Vetter E.A., et al. Optimal testing parameters for blood cultures. Clin Infect Dis 2004, 38(12):1724-1730.
12. Ziegler R., Johnscher I., Martus P., et al. Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections. JClin Microbiol 1998, 36(3):657-661.
13. Lee A., Mirrett S., Reller L.B., et al. Detection of bloodstream infections in adults: how many blood cultures are needed?. JClin Microbiol 2007, 45(11):3546-3548.
14. Richter S.S., Beekmann S.E., Croco J.L., et al. Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. JClin Microbiol 2002, 40(7):2437-2444.
15. Weinstein M.P. Blood culture contamination: persisting problems and partial progress. JClin Microbiol 2003, 41(6):2275-2278.
16. Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39(3):309-317.
17. Munson E.L., Diekema D.J., Beekmann S.E., et al. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. JClin Microbiol 2003, 41(1):495-497.
18. Wolk D.M., Dunne W.M. New technologies in clinical microbiology. JClin Microbiol 2011, 49(9S):S62-S67.
19. Parta M., Goebel M., Matloobi M., et al. Identification of methicillin-resistant or methicillin-susceptible Staphylococcus aureus in blood cultures and wound swabs by GeneXpert. JClin Microbiol 2009, 47(5):1609-1610.
20. Wolk D.M., Struelens M.J., Pancholi P., et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. JClin Microbiol 2009, 47(3):823-826.
21. Spencer D.H., Sellenriek P., Burnham C.A. Validation and implementation of the GeneXpert MRSA/SA blood culture assay in a pediatric setting. Am J Clin Pathol 2011, 136(5):690-694.
22. Kelley P.G., Grabsch E.A., Farrell J., et al. Evaluation of the Xpert MRSA/SA Blood Culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens. Diagn Microbiol Infect Dis 2011, 70(3):404-407.
23. FDA. Corrective action notice for Cepheid MRSA/SA blood culture assay. 2010. Available at:. Accessed December 31, 2012. http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm218002.htm.
24. Vincent M., Xu Y., Kong H. Helicase-dependent isothermal DNA amplification. EMBO Rep 2004, 5(8):795-800.
25. Pasko C., Hicke B., Dunn J., et al. Staph ID/R: a rapid method for determining Staphylococcus species identity and detecting the mecA gene directly from positive blood culture. JClin Microbiol 2012, 50(3):810-817.
26. BD. GeneOhm StaphSR Assay. 2012. Available at:. Accessed December 31, 2012. http://www.bd.com/geneohm/english/products/idi_staphsr.asp.
27. BD. BD MAX System. 2012. Available at:. Accessed December 31, 2012. http://www.bd.com/geneohm/english/products/max/.
28. Stamper P.D., Cai M., Howard T., et al. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. JClin Microbiol 2007, 45(7):2191-2196.
29. Grobner S., Dion M., Plante M., et al. Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles. JClin Microbiol 2009, 47(6):1689-1694.
30. Huletsky A., Giroux R., Rossbach V., et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. JClin Microbiol 2004, 42(5):1875-1884.
31. Oberdorfer K., Pohl S., Frey M., et al. Evaluation of a single-locus real-time polymerase chain reaction as a screening test for specific detection of methicillin-resistant Staphylococcus aureus in ICU patients. Eur J Clin Microbiol Infect Dis 2006, 25(10):657-663.
32. Stamper P.D., Louie L., Wong H., et al. Genotypic and phenotypic characterization of methicillin-susceptible Staphylococcus aureus isolates misidentified as methicillin-resistant Staphylococcus aureus by the BD GeneOhm MRSA assay. JClin Microbiol 2011, 49(4):1240-1244.
33. Snyder J.W., Munier G.K., Heckman S.A., et al. Failure of the BD GeneOhm StaphSR assay for direct detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates in positive blood cultures collected in the United States. JClin Microbiol 2009, 47(11):3747-3748.
34. Thomas L., van Hal S., O'Sullivan M., et al. Failure of the BD GeneOhm StaphS/R assay for identification of Australian methicillin-resistant Staphylococcus aureus strains: duplex assays as the "gold standard" in settings of unknown SCCmec epidemiology. JClin Microbiol 2008, 46(12):4116-4117.
35. Bartels M.D., Boye K., Rohde S.M., et al. Acommon variant of staphylococcal cassette chromosome mec type IVa in isolates from Copenhagen, Denmark, is not detected by the BD GeneOhm methicillin-resistant Staphylococcus aureus assay. JClin Microbiol 2009, 47(5):1524-1527.
36. Boyle-Vavra S., Daum R.S. Reliability of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) assay in detecting MRSA isolates with a variety of genotypes from the United States and Taiwan. JClin Microbiol 2010, 48(12):4546-4551.
37. Nanosphere. Gold Nanoparticle Technology. 2012. Available at:. Accessed December 31, 2012. http://www.nanosphere.us/page/gold-nanoparticle-technology.
38. Buchan B.W., Peterson J.F., Cogbill C.H., et al. Evaluation of a microarray-based genotyping assay for the rapid detection of cytochrome P450 2C19 *2 and *3 polymorphisms from whole blood using nanoparticle probes. Am J Clin Pathol 2011, 136(4):604-608.
39. Tormo N., Medina R., Ocete M.D., et al. Performance of the Nanosphere's Verigene BC-GP test for rapid detection of Gram-positive bacteria and resistance determinants directly from positive blood cultures (poster) 2012, ECCMID, London (UK).
40. Nanosphere. Gram-negative blood culture. 2012. Available at:. Accessed December 31, 2012. http://www.nanosphere.us/product/gram-negative-blood-culture.
41. Anderson C., Kaul K., Voss B., et al. Evaluation of the Verigene Gram-Positive Blood Culture Test (BC-GP) (poster) 2012, ASM, San Francisco (CA).
42. Buchan B.W., Mackey T.L., Cahak C., et al. Rapid detection of Gram-positive bacteria and resistance determinants directly from positive blood cultures using the microarray-based sample-to-result Verigene BC-GP assay (poster) 2012, ECCMID, London (UK).
43. BioFire. FilmArray Blood Culture ID Panel. 2012. Available at:. Accessed December 31, 2012. http://www.biofiredx.com/FilmArray/FutureApplications.html.
44. Blaschke A.J., Heyrend C., Byington C.L., et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 2012, 74(4):349-355.
45. Jordan J.A., Butchko A.R., Durso M.B. Use of pyrosequencing of 16S rRNA fragments to differentiate between bacteria responsible for neonatal sepsis. JMol Diagn 2005, 7(1):105-110.
46. Haanpera M., Jalava J., Huovinen P., et al. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. JClin Microbiol 2007, 45(3):762-770.
47. Motoshima M., Yanagihara K., Morinaga Y., et al. Identification of bacteria directly from positive blood culture samples by DNA pyrosequencing of the 16S rRNA gene. JMed Microbiol 2012, 61(Pt 11):1556-1562.
48. Innings A., Krabbe M., Ullberg M., et al. Identification of 43 Streptococcus species by pyrosequencing analysis of the rnpB gene. JClin Microbiol 2005, 43(12):5983-5991.
49. Jordan J.A., Jones-Laughner J., Durso M.B. Utility of pyrosequencing in identifying bacteria directly from positive blood culture bottles. JClin Microbiol 2009, 47(2):368-372.
50. Quiles-Melero I., Garcia-Rodriguez J., Romero-Gomez M.P., et al. Rapid identification of yeasts from positive blood culture bottles by pyrosequencing. Eur J Clin Microbiol Infect Dis 2011, 30(1):21-24.
51. Kaleta E.J., Clark A.E., Johnson D.R., et al. Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. JClin Microbiol 2011, 49(1):345-353.
52. Jeng K., Gaydos C.A., Blyn L.B., et al. Comparative analysis of two broad-range PCR assays for pathogen detection in positive-blood-culture bottles: PCR-high-resolution melting analysis versus PCR-mass spectrometry. JClin Microbiol 2012, 50(10):3287-3292.
53. Endimiani A., Hujer K.M., Hujer A.M., et al. Rapid identification of bla KPC-possessing Enterobacteriaceae by PCR/electrospray ionization-mass spectrometry. JAntimicrob Chemother 2010, 65(8):1833-1834.
54. Wolk D.M., Blyn L.B., Hall T.A., et al. Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype. JClin Microbiol 2009, 47(10):3129-3137.
55. Hujer K.M., Hujer A.M., Endimiani A., et al. Rapid determination of quinolone resistance in Acinetobacter spp. JClin Microbiol 2009, 47(5):1436-1442.
56. Roche. LightCycler SeptiFast MGRADE Test 2012. Available at:. Accessed December 31, 2012. http://molecular.roche.com/assays/Pages/LightCyclerSeptiFastTestMGRADE.aspx.
57. Lehmann L.E., Hunfeld K.P., Emrich T., et al. Amultiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008, 197(3):313-324.
58. Arpi M., Bentzon M.W., Jensen J., et al. Importance of blood volume cultured in the detection of bacteremia. Eur J Clin Microbiol Infect Dis 1989, 8(9):838-842.
59. Ilstrup D.M., Washington J.A. The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis 1983, 1(2):107-110.
60. Kreger B.E., Craven D.E., Carling P.C., et al. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980, 68(3):332-343.
61. Kellogg J.A., Manzella J.P., Bankert D.A. Frequency of low-level bacteremia in children from birth to fifteen years of age. JClin Microbiol 2000, 38(6):2181-2185.
62. Rath P.M., Saner F., Paul A., et al. Multiplex PCR for rapid and improved diagnosis of bloodstream infections in liver transplant recipients. JClin Microbiol 2012, 50(6):2069-2071.
63. Josefson P., Stralin K., Ohlin A., et al. Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections. Eur J Clin Microbiol Infect Dis 2011, 30(9):1127-1134.
64. Mencacci A., Leli C., Montagna P., et al. Diagnosis of infective endocarditis: comparison of the LightCycler SeptiFast real-time PCR with blood culture. JMed Microbiol 2012, 61(Pt 6):881-883.
65. Lucignano B., Ranno S., Liesenfeld O., et al. Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis. JClin Microbiol 2011, 49(6):2252-2258.
66. Dubska L., Vyskocilova M., Minarikova D., et al. LightCycler SeptiFast technology in patients with solid malignancies: clinical utility for rapid etiologic diagnosis of sepsis. Crit Care 2012, 16(1):404.
67. Mauro M.V., Cavalcanti P., Perugini D., et al. Diagnostic utility of LightCycler SeptiFast and procalcitonin assays in the diagnosis of bloodstream infection in immunocompromised patients. Diagn Microbiol Infect Dis 2012, 73(4):308-311.
68. Casalta J.P., Gouriet F., Roux V., et al. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 2009, 28(6):569-573.
69. Varani S., Stanzani M., Paolucci M., et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. JInfect 2009, 58(5):346-351.
70. Mobidiag. Prove-it Sepsis bacterial and fungal targets. 2012. Available at:. Accessed December 31, 2012. http://www.mobidiag.com/Products/ProveittradeSepsis/ProveittradeSepsisStripArray/tabid/242/Default.aspx.
71. Tissari P., Zumla A., Tarkka E., et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 2010, 375(9710):224-230.
72. Wellinghausen N., Wirths B., Essig A., et al. Evaluation of the Hyplex BloodScreen Multiplex PCR-enzyme-linked immunosorbent assay system for direct identification of gram-positive cocci and gram-negative bacilli from positive blood cultures. JClin Microbiol 2004, 42(7):3147-3152.
73. Molzym. SepsiTest. 2012. Available at:. Accessed December 31, 2012. http://www.sepsitest.com/lab-diagnostics.html.
74. Wellinghausen N., Kochem A.J., Disque C., et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. JClin Microbiol 2009, 47(9):2759-2765.
75. Kuhn C., Disque C., Muhl H., et al. Evaluation of commercial universal rRNA gene PCR plus sequencing tests for identification of bacteria and fungi associated with infectious endocarditis. JClin Microbiol 2011, 49(8):2919-2923.
76. Carretto E., Bardaro M., Russello G., et al. Comparison of the Staphylococcus QuickFISH BC test with the tube coagulase test performed on positive blood cultures for evaluation and application in a clinical routine setting. JClin Microbiol 2013, 51(1):131-135.
77. Chapin K., Musgnug M. Evaluation of three rapid methods for the direct identification of Staphylococcus aureus from positive blood cultures. JClin Microbiol 2003, 41(9):4324-4327.
78. Goldstein J., Roberts J.W. Microtube coagulase test for detection of coagulase-positive staphylococci. JClin Microbiol 1982, 15(5):848-851.
79. McDonald C.L., Chapin K. Rapid identification of Staphylococcus aureus from blood culture bottles by a classic 2-hour tube coagulase test. JClin Microbiol 1995, 33(1):50-52.
80. Speers D.J., Olma T.R., Gilbert G.L. Evaluation of four methods for rapid identification of Staphylococcus aureus from blood cultures. JClin Microbiol 1998, 36(4):1032-1034.
81. Sturm P.D., Kwa D., Vos F.J., et al. Performance of two tube coagulase methods for rapid identification of Staphylococcus aureus from blood cultures and their impact on antimicrobial management. Clin Microbiol Infect 2008, 14(5):510-513.
82. Qian Q., Eichelberger K., Kirby J.E. Rapid identification of Staphylococcus aureus in blood cultures by use of the direct tube coagulase test. JClin Microbiol 2007, 45(7):2267-2269.
83. Varettas K., Mukerjee C., Taylor P.C. Anticoagulant carryover may influence clot formation in direct tube coagulase tests from blood cultures. JClin Microbiol 2005, 43(9):4613-4615.
84. Madison B.M., Baselski V.S. Rapid identification of Staphylococcus aureus in blood cultures by thermonuclease testing. JClin Microbiol 1983, 18(3):722-724.
85. Ratner H.B., Stratton C.W. Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. JClin Microbiol 1985, 21(6):995-996.
86. Bergh K., Maeland J.A. Same-day confirmation of Staphylococcus aureus bacteraemia by a thermonuclease test. Acta Pathol Microbiol Immunol Scand B 1986, 94(4):291-292.
87. Skulnick M., Simor A.E., Patel M.P., et al. Evaluation of three methods for the rapid identification of Staphylococcus aureus in blood cultures. Diagn Microbiol Infect Dis 1994, 19(1):5-8.
88. Lagace-Wiens P.R., Alfa M.J., Manickam K., et al. Thermostable DNase is superior to tube coagulase for direct detection of Staphylococcus aureus in positive blood cultures. JClin Microbiol 2007, 45(10):3478-3479.
89. Murray P.R. Modification of the bile solubility test for rapid identification of Streptococcus pneumoniae. JClin Microbiol 1979, 9(2):290-291.
90. Wetkowski M.A., Peterson E.M., de la Maza L.M. Direct testing of blood cultures for detection of streptococcal antigens. JClin Microbiol 1982, 16(1):86-91.
91. Shlaes D.M., Toossi Z., Patel A. Comparison of latex agglutination and immunofluorescence for direct Lancefield grouping of streptococci from blood cultures. JClin Microbiol 1984, 20(2):195-198.
92. Lupetti A., Barnini S., Castagna B., et al. Rapid identification and antimicrobial susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 system. Eur J Clin Microbiol Infect Dis 2010, 29(1):89-95.
93. Lupetti A., Barnini S., Castagna B., et al. Rapid identification and antimicrobial susceptibility testing of Gram-positive cocci in blood cultures by direct inoculation into the BD Phoenix system. Clin Microbiol Infect 2010, 16(7):986-991.
94. Lupetti A., Barnini S., Morici P., et al. Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system. Eur J Clin Microbiol Infect Dis 2013, 32(4):493-502.
95. Bruins M.J., Bloembergen P., Ruijs G.J., et al. Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2. JClin Microbiol 2004, 42(1):7-11.
96. Chen J.R., Lee S.Y., Yang B.H., et al. Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures. JMicrobiol Immunol Infect 2008, 41(3):259-264.
97. de Cueto M., Ceballos E., Martinez-Martinez L., et al. Use of positive blood cultures for direct identification and susceptibility testing with the Vitek 2 system. JClin Microbiol 2004, 42(8):3734-3738.
98. Gherardi G., Angeletti S., Panitti M., et al. Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. Diagn Microbiol Infect Dis 2012, 72(1):20-31.
99. Ling T.K., Liu Z.K., Cheng A.F. Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of Gram-negative bacilli from positive blood cultures. JClin Microbiol 2003, 41(10):4705-4707.
100. Munoz-Davila M.J., Yague G., Albert M., et al. Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles. Eur J Clin Microbiol Infect Dis 2012, 31(5):663-669.
101. Yonetani S., Okazaki M., Araki K., et al. Direct inoculation method using BacT/ALERT 3D and BD Phoenix System allows rapid and accurate identification and susceptibility testing for both Gram-positive cocci and Gram-negative rods in aerobic blood cultures. Diagn Microbiol Infect Dis 2012, 73(2):129-134.
102. Beuving J., van der Donk C.F., Linssen C.F., et al. Evaluation of direct inoculation of the BD PHOENIX system from positive BACTEC blood cultures for both Gram-positive cocci and Gram-negative rods. BMC Microbiol 2011, 11:156.
103. Funke G., Funke-Kissling P. Use of the BD PHOENIX Automated Microbiology System for direct identification and susceptibility testing of Gram-negative rods from positive blood cultures in a three-phase trial. JClin Microbiol 2004, 42(4):1466-1470.
104. Colakoglu S., Aliskan H., Senger S.S., et al. Performance of MRSA ID chromogenic medium for detection of methicillin-resistant Staphylococcus aureus directly from blood cultures and clinical specimens. Diagn Microbiol Infect Dis 2007, 59(3):319-323.
105. Murray C.K., Beckius M.L., Green J.A., et al. Use of chromogenic medium in the isolation of yeasts from clinical specimens. JMed Microbiol 2005, 54(Pt 10):981-985.
106. Tan G.L., Peterson E.M. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. JClin Microbiol 2005, 43(4):1727-1731.
107. Ghelardi E., Pichierri G., Castagna B., et al. Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species. Clin Microbiol Infect 2008, 14(2):141-147.
108. Alere. BinaxNOW Staphylococcus aureus card product insert. 2012. Available at:. Accessed December 31, 2012. http://www.alere.com/us/en/product-details/binaxnow-s-aureus.html.
109. Romero-Gomez M.P., Quiles-Melero I., Navarro C., et al. Evaluation of the BinaxNOW PBP2a assay for the direct detection of methicillin resistance in Staphylococcus aureus from positive blood culture bottles. Diagn Microbiol Infect Dis 2012, 72(3):282-284.
110. Study of the performance of the KeyPath MRSA/MSSA blood culture test - BTA. Available at:. Accessed November 20, 2012. http://clinicaltrials.gov/ct2/show/NCT01640886.
111. Bhowmick T., Mirrett S., Reller L., et al. Controlled multicenter evaluation of a bacteriophage based method for the rapid detection of Staphylococcus aureus in positive blood cultures (poster) 2011, ASM, New Orleans (LA).
112. Kingery J., Stamper P., Peterson L., et al. Anovel phage technology for the detection of S. aureus and differentiation of MSSA and MRSA in positive blood culture bottles (poster) 2009, ASM, Philadelphia (PA).
113. Dreiling B., Reed K., Steinmark T., et al. The Keypath MRSA/MSSA blood culture test - BT accurately identifies S. aureus isolates that carry incomplete SCC elements (mecA dropouts) as MSSA (poster) 2011, IDSA, Boston (MA).
114. Nielsen P.E., Egholm M. An introduction to peptide nucleic acid. Curr Issues Mol Biol 1999, 1(1-2):89-104.
115. Stender H., Fiandaca M., Hyldig-Nielsen J.J., et al. PNA for rapid microbiology. JMicrobiol Methods 2002, 48(1):1-17.
116. Deck M.K., Anderson E.S., Buckner R.J., et al. Multicenter evaluation of the Staphylococcus QuickFISH method for simultaneous identification of Staphylococcus aureus and coagulase-negative staphylococci directly from blood culture bottles in less than 30 minutes. JClin Microbiol 2012, 50(6):1994-1998.
117. Alexander B.D., Ashley E.D., Reller L.B., et al. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis 2006, 54(4):277-282.
118. Forrest G.N., Mehta S., Weekes E., et al. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. JAntimicrob Chemother 2006, 58(1):154-158.
119. Heil E.L., Daniels L.M., Long D.M., et al. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm 2012, 69(21):1910-1914.
120. Ly T., Gulia J., Pyrgos V., et al. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 2008, 4(3):637-640.
121. Forrest G.N., Roghmann M.C., Toombs L.S., et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008, 52(10):3558-3563.
122. Metzger S., Price C.S., Hance K., et al. Same-day blood culture with digital microscopy (poster) 2012, ICAAC, San Francisco (CA).
123. Loonen A.J., Jansz A.R., Stalpers J., et al. An evaluation of three processing methods and the effect of reduced culture times for faster direct identification of pathogens from BacT/ALERT blood cultures by MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 2012, 31(7):1575-1583.
124. Juiz P.M., Almela M., Melcion C., et al. Acomparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 2012, 31(7):1353-1358.
125. Meex C., Neuville F., Descy J., et al. Direct identification of bacteria from BacT/ALERT anaerobic positive blood cultures by MALDI-TOF MS: MALDI Sepsityper kit versus an in-house saponin method for bacterial extraction. JMed Microbiol 2012, 61(Pt 11):1511-1516.
126. Klein S., Zimmermann S., Kohler C., et al. Integration of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in blood culture diagnostics: a fast and effective approach. JMed Microbiol 2012, 61(Pt 3):323-331.
127. Buchan B.W., Riebe K.M., Ledeboer N.A. Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles. JClin Microbiol 2012, 50(2):346-352.
128. Moussaoui W., Jaulhac B., Hoffmann A.M., et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials. Clin Microbiol Infect 2010, 16(11):1631-1638.
129. La Scola B., Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One 2009, 4(11):e8041.
130. Romero-Gomez M.P., Mingorance J. The effect of the blood culture bottle type in the rate of direct identification from positive cultures by matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry. JInfect 2011, 62(3):251-253.
131. Wimmer J.L., Long S.W., Cernoch P., et al. Strategy for rapid identification and antibiotic susceptibility testing of Gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system. JClin Microbiol 2012, 50(7):2452-2454.
132. Ferreira L., Sanchez-Juanes F., Porras-Guerra I., et al. Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2011, 17(4):546-551.
133. Stevenson L.G., Drake S.K., Murray P.R. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2010, 48(2):444-447.
134. Spanu T., Posteraro B., Fiori B., et al. Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. JClin Microbiol 2012, 50(1):176-179.
135. Fothergill A., Kasinathan V., Hyman J., et al. Rapid identification of bacteria and yeasts from positive BacT/ALERT blood culture bottles by using a lysis-filtration method and MALDI-TOF mass spectrum analysis with SARAMIS database. JClin Microbiol 2013, 51(3):805-809.
136. Schmidt V., Jarosch A., Marz P., et al. Rapid identification of bacteria in positive blood culture by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Eur J Clin Microbiol Infect Dis 2012, 31(3):311-317.
137. Kaleta E.J., Clark A.E., Cherkaoui A., et al. Comparative analysis of PCR-electrospray ionization/mass spectrometry (MS) and MALDI-TOF/MS for the identification of bacteria and yeast from positive blood culture bottles. Clin Chem 2011, 57(7):1057-1067.
138. Prod'hom G., Bizzini A., Durussel C., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. JClin Microbiol 2010, 48(4):1481-1483.
139. Pletz M.W., Wellinghausen N., Welte T. Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view. Intensive Care Med 2011, 37(7):1069-1076.
140. Forrest G.N., Mankes K., Jabra-Rizk M.A., et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. JClin Microbiol 2006, 44(9):3381-3383.
141. Bauer K.A., West J.E., Balada-Llasat J.M., et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010, 51(9):1074-1080.
142. Parta M., Goebel M., Thomas J., et al. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol 2010, 31(10):1043-1048.
143. Blot S.I., Vandewoude K.H., Hoste E.A., et al. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002, 162(19):2229-2235.
144. McHugh C.G., Riley L.W. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infect Control Hosp Epidemiol 2004, 25(5):425-430.
145. Cattoir V., Merabet L., Djibo N., et al. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures. Clin Microbiol Infect 2011, 17(3):425-431.
146. Chihara S., Hayden M.K., Minogue-Corbett E., et al. Shortened time to identify Staphylococcus species from blood cultures and methicillin resistance testing using CHROMagar. Int J Microbiol 2009, 2009:636502.
147. Pape J., Wadlin J., Nachamkin I. Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. JClin Microbiol 2006, 44(7):2575-2576.
148. Wendt C., Havill N.L., Chapin K.C., et al. Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in different specimens. JClin Microbiol 2010, 48(6):2223-2227.
149. Riedel S., Dam L., Stamper P.D., et al. Evaluation of Bio-Rad MRSASelect agar for detection of methicillin-resistant Staphylococcus aureus directly from blood cultures. JClin Microbiol 2010, 48(6):2285-2288.
150. Peterson J.F., Dionisio A.A., Riebe K.M., et al. Alternative use for Spectra MRSA chromogenic agar in detection of methicillin-resistant Staphylococcus aureus from positive blood cultures. JClin Microbiol 2010, 48(6):2265-2267.
151. Hensley D.M., Tapia R., Encina Y. An evaluation of the AdvanDx Staphylococcus aureus/CNS PNA FISH assay. Clin Lab Sci 2009, 22(1):30-33.
152. Morgan M.A., Marlowe E., Novak-Weekly S., et al. A1.5 hour procedure for identification of Enterococcus species directly from blood cultures. JVis Exp 2011, (48). pii:2616.
153. Della-Latta P., Salimnia H., Painter T., et al. Identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa in blood cultures: a multicenter performance evaluation of a three-color peptide nucleic acid fluorescence in situ hybridization assay. JClin Microbiol 2011, 49(6):2259-2261.
154. Hall L., Le Febre K.M., Deml S.M., et al. Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures. JClin Microbiol 2012, 50(4):1446-1448.